From Structure to Function: In Vivo Molecular Imaging

Table of Contents

• Executive Summary
  • Strategic Considerations
  • Stakeholder Implications
• Introduction
• Factors Driving the Development and Adoption of In Vivo Imaging
  • Trend Toward Systems Biology
  • Trend Toward Personalized Medicine
  • FDA Critical Path Initiative
  • Exploratory IND and Microdosing Studies
• In Vivo Imaging Technologies
  • Computed Tomography
  • Positron Emission Tomography
  • Single Photon Emission Computed Tomography
  • Magnetic Resonance Imaging
  • Functional Magnetic Resonance Imaging
  • Optical Imaging
• Imaging Initiatives
  • Biomarker Consortium
  • Alzheimer's Disease Neuroimaging Initiative
  • Lung Cancer Initiative
  • Osteoarthritis Initiative
• In Vivo Imaging with Model Organisms
  • Biophotonic Mice
  • Zebrafish
• Applications of Imaging to Cancer
• Applications of Imaging to the Brain and CNS Disorders
• Corporate Profiles
  • Gamma Medica-Ideas
  • GE Healthcare
  • Varian
  • VisEn Medical
  • Xenogen
  • Zecotek Medical Systems
  • Zygogen
• Outlook for Molecular Imaging

Tables

• 1. In Vivo Molecular Imaging Techniques: Strengths, Weaknesses, and Opportunities
• 2. Applications of Select In Vivo Imaging Approaches
• 3. Select Companies Active in In Vivo Imaging
• 4. Select Alliances and Acquisitions in the In Vivo Imaging Field

Figures

• 1. Growth in Publications on In Vivo Imaging Research
• 2. Trend Toward Quantitative In Vivo Imaging Models
• 3. FDG Uptake in a Xenograft Tumor in Mouse